Category: Latest News
-
App helps save Seattle cardiac patient
SEATTLE (AP) — If your heart is going to stop, right outside a hospital is not a bad place for it.
-
Judge questions vow not to use sedative again in executions
PHOENIX (AP) — A judge presiding over a lawsuit that protests how Arizona carries out the death penalty extracted promises in court from the state Wednesday that it won't use the sedative midazolam in future executions.
-
Judge questions vow not to use sedative again in executions
PHOENIX (AP) — A judge presiding over a lawsuit that protests how Arizona carries out the death penalty extracted promises in court from the state Wednesday that it won't use the sedative midazolam in future executions.
-
UnitedHealth sees more growth in 2017 when it exits Obamacare
The company said losses in that business were within expectations in the third quarter, news that boosted the recently weak shares of competitors like Anthem Inc , which plan to stay in those markets next year. Shares of UnitedHealth, which beat Wall Street third-quarter earnings estimates, raised its full-year outlook and signaled 2017 earnings could…
-
St. Jude and Abbott to sell some medical devices for $1.12 billion
(Reuters) – Abbott Laboratories, which is in the process of buying St. Jude Medical Inc for $25 billion, said the companies would sell some of their medical devices to Japan-based Terumo Corp for about $1.12 billion. Abbott said on Tuesday the deal is an important step toward completion of the St. Jude acquisition, which is…
-
J&J says pharma future bright, despite threat to Remicade
Pfizer Inc late on Monday said it would begin U.S. shipments of Inflectra, its biosimilar form of Remicade, by late November at a 15 percent discount to J&J's current wholesale prices. With annual U.S. sales of about $5 billion, Remicade is J&J's biggest product. “We are confident our pharma business will go well with or…
-
Approval rating of Peru’s Kuczynski drops 8 points after scandal
Peruvian President Pedro Pablo Kuczynski's approval rating dropped 8 percentage points to 55 percent after a corruption scandal forced him to fire his health adviser, an Ipsos poll published in a newspaper showed on Sunday. Kuczynski's popularity had risen to 63 percent through September after a razor-thin victory in June's run-off election against right-wing populist…
-
Approval rating of Peru’s Kuczynski drops 8 points after scandal
Peruvian President Pedro Pablo Kuczynski's approval rating dropped 8 percentage points to 55 percent after a corruption scandal forced him to fire his health adviser, an Ipsos poll published in a newspaper showed on Sunday. Kuczynski's popularity had risen to 63 percent through September after a razor-thin victory in June's run-off election against right-wing populist…